| Christine Da Silva, MD | |
|
769 N Clyde Morris Blvd, Daytona Beach, FL 32114-1603 | |
| (386) 258-0123 | |
| (386) 258-6464 |
| Full Name | Christine Da Silva |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 769 N Clyde Morris Blvd, Daytona Beach, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366447195 | NPI | - | NPPES |
| 258583900 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | ME70418 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Daytona Beach | Daytona beach, FL | Hospital |
| Halifax Health Medical Center | Daytona beach, FL | Hospital |
| Adventhealth Deland | Deland, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vitalmd Group Holding Llc | 8921091786 | 428 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
The Allen Institute for Brain Science announced today the discovery of a new class of cells in the spinal cord that act like neural stem cells, offering a fresh avenue in the search for therapies to treat spinal cord injury and disease.
Results of recent clinical trials carried out on type 1 diabetics by Nemaura Pharma using its Memspatch Insulin Micro-needle Device (IMD) will come as a relief to those who fear needles and injections, a condition medically known as trypanophobia, affecting 10 percent of the world's population.
Medasys Inc., a medical device company focused on providing implantable drug delivery solutions, announced today that it has received PMA approval from the U. S. Food and Drug Administration for its Prometra programmable implantable drug pump.
› Verified 8 days ago
| Entity Name | Vitalmd Group Holding Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871572032 PECOS PAC ID: 8921091786 Enrollment ID: O20040406001878 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
The Allen Institute for Brain Science announced today the discovery of a new class of cells in the spinal cord that act like neural stem cells, offering a fresh avenue in the search for therapies to treat spinal cord injury and disease.
Results of recent clinical trials carried out on type 1 diabetics by Nemaura Pharma using its Memspatch Insulin Micro-needle Device (IMD) will come as a relief to those who fear needles and injections, a condition medically known as trypanophobia, affecting 10 percent of the world's population.
Medasys Inc., a medical device company focused on providing implantable drug delivery solutions, announced today that it has received PMA approval from the U. S. Food and Drug Administration for its Prometra programmable implantable drug pump.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Da Silva, MD 769 N Clyde Morris Blvd, Daytona Beach, FL 32114-1603 Ph: (386) 258-0123 | Christine Da Silva, MD 769 N Clyde Morris Blvd, Daytona Beach, FL 32114-1603 Ph: (386) 258-0123 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
The Allen Institute for Brain Science announced today the discovery of a new class of cells in the spinal cord that act like neural stem cells, offering a fresh avenue in the search for therapies to treat spinal cord injury and disease.
Results of recent clinical trials carried out on type 1 diabetics by Nemaura Pharma using its Memspatch Insulin Micro-needle Device (IMD) will come as a relief to those who fear needles and injections, a condition medically known as trypanophobia, affecting 10 percent of the world's population.
Medasys Inc., a medical device company focused on providing implantable drug delivery solutions, announced today that it has received PMA approval from the U. S. Food and Drug Administration for its Prometra programmable implantable drug pump.
› Verified 8 days ago
Dr. John A White, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 533 N. Clyde Morris Blvd, Ste A, Daytona Beach, FL 32114 Phone: 386-255-0901 Fax: 386-255-4454 | |
Dr. Randall Brooks Whitney, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 580 Mulberry St, Daytona Beach, FL 32114 Phone: 386-238-0633 Fax: 386-254-8227 | |
Stephen James Cortez, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1890 Lpga Blvd, Ste. 160, Daytona Beach, FL 32117 Phone: 386-252-4701 Fax: 386-253-9410 | |
Dr. Meetesh Desai, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 500 Health Blvd, Daytona Beach, FL 32114 Phone: 386-252-5858 | |
Dr. Gary Goodenow, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-254-4121 Fax: 386-258-4802 | |
Dr. John C Meyers, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 769 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-258-0123 Fax: 386-258-6882 |